Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-propanamine, 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethyl-
2. 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethyl-1-propanamine
3. Ttp488
1. 603148-36-3
2. Ttp488
3. Azeliragon [inn]
4. Azeliragon Free Base
5. Pf-04494700
6. Azeliragon [usan]
7. Ttp-488
8. Lpu25f15uq
9. Ttp488;pf-04494700
10. 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethylpropan-1-amine
11. Ttp448
12. 603148-36-3 (free Base)
13. 1-propanamine, 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethyl-
14. 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]imidazol-4-yl]phenoxy]-n,n-diethylpropan-1-amine
15. Unii-lpu25f15uq
16. 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1h-imidazol-4-yl)phenoxy)-n,n-diethyl-1-propanamine
17. 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1h-imidazol-4-yl]phenoxy]-n,n-diethyl-1-propanamine
18. Azeliragon (usan/inn)
19. Azeliragon [usan:inn]
20. Azeliragon [who-dd]
21. Gtpl8317
22. Schembl1142599
23. Chembl3989929
24. Dtxsid601117468
25. Amy17088
26. Bcp16862
27. Ex-a1834
28. Bdbm50249580
29. Mfcd11977600
30. S6415
31. Zinc38336973
32. Akos026750516
33. Azeliragonpf-04494700,ttp488
34. Cs-5117
35. Db12689
36. Sb19818
37. Ac-35831
38. As-49837
39. Hy-50682
40. D11147
41. N11192
42. Q27074825
43. 1-propanamine,3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1h-imidazol-4-yl]phenoxy]-n,n-diethyl-
44. 1421852-66-5
| Molecular Weight | 532.1 g/mol |
|---|---|
| Molecular Formula | C32H38ClN3O2 |
| XLogP3 | 8.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 14 |
| Exact Mass | 531.2652552 g/mol |
| Monoisotopic Mass | 531.2652552 g/mol |
| Topological Polar Surface Area | 39.5 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Azeliragon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azeliragon, including repackagers and relabelers. The FDA regulates Azeliragon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azeliragon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Azeliragon supplier is an individual or a company that provides Azeliragon active pharmaceutical ingredient (API) or Azeliragon finished formulations upon request. The Azeliragon suppliers may include Azeliragon API manufacturers, exporters, distributors and traders.
Azeliragon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azeliragon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azeliragon GMP manufacturer or Azeliragon GMP API supplier for your needs.
A Azeliragon CoA (Certificate of Analysis) is a formal document that attests to Azeliragon's compliance with Azeliragon specifications and serves as a tool for batch-level quality control.
Azeliragon CoA mostly includes findings from lab analyses of a specific batch. For each Azeliragon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azeliragon may be tested according to a variety of international standards, such as European Pharmacopoeia (Azeliragon EP), Azeliragon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azeliragon USP).
